JUN and melanoma: The findings that follow support the impact of ARSB and chondroitin 4-sulfation on galectin-3, c-Jun, HDAC3, and H3 on the regulation of PD-L1 expression in melanoma and suggest that ARSB may help with checkpoint inhibition.